Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)

Document Type:Grants NoticeFunding Opportunity Number:PAR-23-180Funding Opportunity Title:Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:HealthIncome Security and Social ServicesCategory Explanation: Expected Number of Awards: CFDA Number(s):93.242 -- Mental Health Research Grants 93.855 -- Allergy and Infectious Diseases Research 93.865 -- Child Health and Human Development Extramural ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:May 09, 2023Last Updated Date:May 09, 2023Original Closing Date for Applications:Dec 07, 2024 Current Closing Date for Applications:Dec 07, 2024 Archive Date:Jan 12, 2025Estimated Total Program Funding: Award Ceiling: Award Floor: Document Type:Grants NoticeFunding Opportunity Number:PAR-23-180Funding Opportunity Title:Next Generation Multipurpose Prevention

Technologies (NGM) (R01 Clinical Trial Optional)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:HealthIncome Security and Social ServicesCategory Explanation: Expected Number of Awards: CFDA Number(s):93.242 -- Mental Health Research Grants 93.855 -- Allergy and Infectious Diseases Research 93.865 -- Child Health and Human Development Extramural ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:May 09, 2023Last Updated Date:May 09, 2023Original Closing Date for Applications:Dec 07, 2024 Current Closing Date for Applications:Dec 07, 2024 Archive Date:Jan 12, 2025Estimated Total Program Funding: Award Ceiling: Award Floor: Eligible Applicants:Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Independent school districts Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) State governments County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Private institutions of higher educationAdditional Information on Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. Agency Name:National Institutes of HealthDescription:The objective of this Notice of Funding Opportunity (NOFO) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy; or multiple non-HIV STI or HIV/STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development, and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety, and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.Link to Additional Information:https://grants.nih.gov/grants/guide/pa-files/PAR-23-180.htmlGrantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information grantsinfo@nih.govSee Section VII. Agency Contacts within the full opportunity announcement for all other inquires.